DD13769A - - Google Patents

Info

Publication number
DD13769A
DD13769A DD13769DA DD13769A DD 13769 A DD13769 A DD 13769A DD 13769D A DD13769D A DD 13769DA DD 13769 A DD13769 A DD 13769A
Authority
DD
German Democratic Republic
Application number
Publication of DD13769A publication Critical patent/DD13769A/xx

Links

DD13769D DD13769A (zh)

Publications (1)

Publication Number Publication Date
DD13769A true DD13769A (zh)

Family

ID=225646

Family Applications (1)

Application Number Title Priority Date Filing Date
DD13769D DD13769A (zh)

Country Status (1)

Country Link
DD (1) DD13769A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104662007B (zh) * 2012-07-25 2018-03-16 索瓦制药公司 胱硫醚‑γ‑裂合酶(CSE)抑制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104662007B (zh) * 2012-07-25 2018-03-16 索瓦制药公司 胱硫醚‑γ‑裂合酶(CSE)抑制剂

Similar Documents

Publication Publication Date Title
AU2018200632B2 (en) Cystathionine-y-lyase (CSE) inhibitors
JP2015524807A5 (zh)
US11021501B2 (en) Creatine phosphate analog prodrugs, compositions and methods of use thereof
US9504655B2 (en) Capsule dosage form of metoprolol succinate
WO2020247819A2 (en) Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulators
US3352909A (en) Novel 4-(organosulfonyl) semicarbazides
DD207626A3 (de) Verfahren zur herstellung des 3-amino-5-hydrazino-1,2,4-triazols und dessen derivaten
DD13769A (zh)